Magle Chemoswed Holding AB (FRA:52X) Total Equity: €25.97 Mil (As of Mar. 2026)


FRA:52X Magle Chemoswed Holding AB FRA:52X
40 GF Score
Price €0.08
GF Value €1.79
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB Total Equity?

Magle Chemoswed Holding AB FRA:52X +25.00% 40 Total Equity is €25.97 Mil as of Mar. 2026. GuruFocus rates FRA:52X with a GF Score™ of 40/100 and a GF Value™ of €1.79. The stock has 6 warning signs investors should review.

Magle Chemoswed Holding AB's total equity for the quarter that ended in Mar. 2026 was €25.97 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Magle Chemoswed Holding AB Total Equity Historical Data

* Premium members only.

The historical data trend for Magle Chemoswed Holding AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magle Chemoswed Holding AB Total Equity Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 13.52 13.35 14.15 48.24 27.53

Magle Chemoswed Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.21 48.06 48.34 27.53 25.97
FRA:52X
40GF Score
Magle Chemoswed Holding AB FRA:52X
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Magle Chemoswed Holding AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Magle Chemoswed Holding AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=75.455-47.93
=27.53

Magle Chemoswed Holding AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=76.474-50.501
=25.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €25.97 Mil mean?
Magle Chemoswed Holding AB (FRA:52X) has a Total Equity of €25.97 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Magle Chemoswed Holding AB and its competitors.
Is Magle Chemoswed Holding AB's Total Equity too high?
Magle Chemoswed Holding AB's current Total Equity is €25.97 Mil. Overall, Magle Chemoswed Holding AB has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Magle Chemoswed Holding AB's Total Equity compare to VRTX and REGN?
Magle Chemoswed Holding AB's Total Equity of €25.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Magle Chemoswed Holding AB and its competitors. Magle Chemoswed Holding AB's current Total Equity is €25.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magle Chemoswed Holding AB stock overvalued right now?
Magle Chemoswed Holding AB (FRA:52X) has a current Total Equity of €25.97 Mil. The stock's GF Value™ is €1.79, compared to a current price of €0.08 — trading 95.5% below its estimated fair value. The current Total Equity is €25.97 Mil. Magle Chemoswed Holding AB's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Magle Chemoswed Holding AB (FRA:52X), the current Total Equity is €25.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Magle Chemoswed Holding AB (FRA:52X) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of €0.08 is trading 95.5% below its estimated GF Value™ of €1.79.

Key valuation signals for FRA:52X:

  • Total Equity: €25.97 Mil
  • GF Value™: €1.79 vs. price of €0.08 (95.5% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:52X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Magle Chemoswed Holding AB Business Description

Other Exchanges MAGLE:Sweden52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
40GF Score

Get the complete analysis for FRA:52X

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.08
Price
€1.79
GF Value